Qingfu Zhang

First Hospital of China Medical University

Papers

1

Total Citations

13

H-Index

1

About

Dr. Qingfu Zhang is a distinguished pathologist whose research centers on the morphological and molecular characterization of rare renal tumors. His major contributions lie in delineating the diagnostic criteria and genetic underpinnings of uncommon renal cell carcinoma (RCC) subtypes, particularly those with overlapping features. In a landmark 2022 study, Dr. Zhang reported a unique case of RCC exhibiting both haemangioblastoma-like features and leiomyomatous stroma, a novel combination that challenges existing classification frameworks. This work, which has garnered 13 citations, identified concurrent *TSC2* and *SETD2* variations, providing critical insights into the molecular drivers of these rare neoplasms. By bridging histopathological observation with genomic analysis, Dr. Zhang has advanced the understanding of provisional WHO entities like RCC with leiomyomatous stroma, aiding in accurate diagnosis and potential targeted therapies. His meticulous case studies and molecular profiling continue to shape the evolving taxonomy of kidney cancers, making him a key contributor to urologic pathology and precision oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Rare renal cell carcinoma with haemangioblastoma-like features and leiomyomatous stroma: report of a unique case with TSC2 and SETD2 variations
13 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: First Hospital of China Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago